The following Life Sciences guidance note Produced in partnership with Jaspreet Takhar of Baker McKenzie provides comprehensive and up to date legal information covering:
Electronic cigarettes (commonly known as ‘e-cigarettes’, ‘vapourisers’ or ‘vapes’) are products that can be used to consume nicotine-containing vapour via a mouth piece. For the purposes of the legislation discussed in this Practice Note, e-cigarettes also include any component of such product (including a cartridge, tank and the product excluding a cartridge or tank).
E-cigarettes work by heating a solution (e-liquid) that typically contains nicotine, propylene glycol and/or vegetable glycerine, and flavourings. E-cigarettes do not contain tobacco (ie leaves and other natural processed or unprocessed parts of tobacco plants), and do not burn or produce carbon monoxide, tar or smoke.
E-cigarettes are therefore distinct from tobacco products and herbal products for smoking. The latter includes products based on plants, herbs or fruits, and does not contain tobacco.
The distinction between ‘e-cigarettes’, ‘tobacco products’ and ‘herbal products for smoking’ is crucial, as they are regulated separately under EU and UK legislation. This Practice Note discusses the regulation of e-cigarettes only.
At a high level, there are three regulatory regimes which may apply to e-cigarettes:
Directive 2014/40/EU, the Tobacco Products Directive (TPD) which regulates tobacco and related products
Directive 2001/83/EC (consolidated version 16.11.2012), the Pharmaceutical Code which regulates medicinal products for human use
Directive 93/42/EEC (consolidated version 11.10.2007), the Medical Devices Directive (MDD) which regulates medical
**excludes LexisPSL Practice Compliance, Practice Management and Risk and Compliance. To discuss trialling these LexisPSL services please email customer service via our online form. Free trials are only available to individuals based in the UK. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
To view the latest version of this document and thousands of others like it, sign-in to LexisPSL or register for a free trial.
Existing user? Sign-in
Take a free trial
Take a free trial
0330 161 1234